Home

Bioworkshops sell "Ofatumumab"

Basic Information

973
50
13
3.9(22)

Trade Type

Sell

Product Name

Ofatumumab

Manufacturer(s)

Specifications

  • Expression System: Optimized mammalian cell line supported by a Drug Master File (DMF) filing, delivering consistently high titers for cost-efficient large-scale manufacturing.
  • Regulatory Status: Cell line developed for global regulatory readiness (DMF filing) supporting this CD20-directed bispecific antibody biosimilar (reference product first approved 2009-10-26, US, for chronic lymphocytic leukemia).
  • Application: CD20-directed antibody biosimilar for neoplasms and immune/nervous system diseases, with chronic lymphocytic leukemia as a representative indication.
  • Purity: Proven high degree of analytical comparability (similarity) to the reference product, supporting regulatory and clinical acceptance as a biosimilar.

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product